Eve Health : Change of Director's Interest Notice x 3

For personal use only

Appendix 3Y

Change of Director's Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/9/2001.

Name of entity EVE Health Group Limited

ABN	89 106 523 611

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Alasdair Campbell Cooke
Date of last notice	1 June 2020

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest	Direct and Indirect
Nature of indirect interest	Glenlaren Pty Ltd
(including registered holder)	Hartree Pty Ltd
Note: Provide details of the circumstances	Mitchell River Group Pty Ltd
giving rise to the relevant interest.	Melissa Louise Cooke (Spouse)
Date of change	31 December 2021
		Direct
		67,360,212 Ordinary Shares
No. of securities held prior to	1,500,000 Performance Rights
change	3,500,000 Unlisted option exercisable at $0.006 by 31 December 2021
		Indirect
		118,514,389 Ordinary Shares
Class	Unlisted option exercisable at $0.006 by 31 December 2021
Number acquired	-
Number disposed	3,500,000
Value/Consideration	-
Note: If consideration is non-cash, provide details
and estimated valuation
		Direct
		67,360,212 Ordinary Shares
No. of securities held after change	1,500,000 Performance Rights
		Indirect
		118,514,389 Ordinary Shares
Nature of change
Example: on-market trade, off-market trade, exercise	Expiry of option
of options, issue of securities under dividend
reinvestment plan, participation in buy-back
	+ See chapter 19 for defined terms.
	Appendix 3Y	Page 1

Appendix 3Y

Change of Director's Interest Notice

Part 2 - Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

For personal use only

Detail of contract

Nature of interest

Name of registered holder (if issued securities)

Date of change

No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed

Interest acquired

Interest disposed

Value/Consideration

Note: If consideration is non-cash, provide details and an estimated valuation

Interest after change

Part 3 - +Closed period

Were the interests in the securities or contracts detailed above traded	No
during a +closed period where prior written clearance was required?
If so, was prior written clearance provided to allow the trade to proceed	N/A
during this period?
If prior written clearance was provided, on what date was this	N/A
provided?

Appendix 3Y	Page
2

For personal use only

Appendix 3Y

Change of Director's Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/9/2001.

Name of entity EVE Health Group Limited

ABN	89 106 523 611

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	George Cameron-Dow
Date of last notice	1 June 2020

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest	Direct and Indirect
Nature of indirect interest
(including registered holder)	Dhow Nominees Pty Ltd ATF Dhow Trust
Note: Provide details of the circumstances
giving rise to the relevant interest.
Date of change	31 December 2021
	Direct
No. of securities held prior to	1,500,000 Performance Rights
Indirect
change
7,999,980 Ordinary Shares
	2,000,000 Unlisted option exercisable at $0.006 by 31 December 2021
Class	Unlisted option exercisable at $0.006 by 31 December 2021
Number acquired	-
Number disposed	2,000,000
Value/Consideration	-
Note: If consideration is non-cash, provide details
and estimated valuation
	Direct
No. of securities held after change	1,500,000 Performance Rights
Indirect
	7,999,980 Ordinary Shares
Nature of change	Expiry of option
Example: on-market trade, off-market trade, exercise
of options, issue of securities under dividend
reinvestment plan, participation in buy-back

+ See chapter 19 for defined terms.
Appendix 3Y	Page 1

Appendix 3Y

Change of Director's Interest Notice

Part 2 - Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

For personal use only

Detail of contract

Nature of interest

Name of registered holder (if issued securities)

Date of change

No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed

Interest acquired

Interest disposed

Value/Consideration

Note: If consideration is non-cash, provide details and an estimated valuation

Interest after change

Part 3 - +Closed period

Were the interests in the securities or contracts detailed above traded	No
during a +closed period where prior written clearance was required?
If so, was prior written clearance provided to allow the trade to proceed	N/A
during this period?
If prior written clearance was provided, on what date was this	N/A
provided?

Appendix 3Y	Page
2

For personal use only

Appendix 3Y

Change of Director's Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/9/2001.

Name of entity EVE Health Group Limited

ABN	89 106 523 611

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Gregory William Fry
Date of last notice	26 November 2021

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest	Direct and Indirect
Nature of indirect interest	The Fry Family Superfund
(including registered holder)
Abigail Fry (spouse)
Note: Provide details of the circumstances giving
rise to the relevant interest.
Date of change	29-31 December 2021
	Direct
	4,141,667 Ordinary Shares
	18,000,000 Performance Rights
No. of securities held prior to	3,333,332 Unlisted options exercisable at $0.006 by 31 December 2021
change	16,000,000 Unlisted options exercisable at $0.016 by 26 November 2024
	Indirect
	27,788,066 Ordinary Shares (Super Fund)
	45,760,124 Ordinary Shares (Abigail Fry)
Class	Ordinary Shares
Number acquired	1,800,000 Ordinary Shares (Super Fund)
Number disposed	3,333,332 Unlisted options exercisable at $0.006 by 31 December 2021
Value/Consideration	$7,200
Note: If consideration is non-cash, provide
details and estimated valuation
	Direct
	4,141,667 Ordinary Shares
No. of securities held after	18,000,000 Performance Rights
16,000,000 Unlisted options exercisable at $0.016 by 26 November 2024
change	Indirect
	29,588,066 Ordinary Shares (Super Fund)
	45,760,124 Ordinary Shares (Abigail Fry)

+ See chapter 19 for defined terms.
Appendix 3Y	Page 1